Nisa Investment Advisors
BIOA

Nisa Investment Advisors’s BioAge Labs BIOA Stock Holding History

Nisa Investment Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Sell
11,977
-760
-6% -$13.7K ﹤0.01% 1122
2026
Q1 		$223K Buy
12,737
+2,500
+24% +$48.1K ﹤0.01% 1180
2025
Q4 		$135K Buy
10,237
+10,000
+4,219% +$88.6K ﹤0.01% 1341
2025
Q3 		$1.39K Hold
237
– – ﹤0.01% 2686
2025
Q2 		$979 Buy
237
+59
+33% +$238 ﹤0.01% 2741
2025
Q1 		$669 Buy
+178
New +$823 ﹤0.01% 2739

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nisa Investment Advisors's BIOA Position: Q2 2026 in Review

Nisa Investment Advisors reduced its BioAge Labs (BIOA) stake by 6% in Q2 2026, selling an estimated $13.7K and leaving 11,977 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Nisa Investment Advisors first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 43 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Nisa Investment Advisors held 11,977 shares of BioAge Labs worth $294K as of Q2 2026.
  • Nisa Investment Advisors sold 760 BioAge Labs shares in Q2 2026, an estimated $13.7K.
  • BioAge Labs made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1122 holding.
  • Nisa Investment Advisors first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 43 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.